Webinar: Implementing NGS for the study of lymphoid malignancies

Learn how NGS can provide fast and complete lymphoid molecular results

Register now

Live Webinar：Tuesday, 13 August 2024

Lymphoproliferative disorders are heterogeneous and complex and can be very challenging to characterize. However, the molecular characterization of the different entities carried out in recent years has revealed characteristic mutational profiles associated with the different lymphoma subtypes. 

During this presentation, Dr. Gerard Frigola, a Hematopathologist at the Hospital Clinic Barcelona, will provide some background on lymphoid malignancies and discuss the benefits of using NGS to analyze lymphoma samples. 

He will also share his experience with the new Ion AmpliSeq™ Liverpool Lymphoid Network Panel, an NGS community panel designed by leading clinical researchers for fast and comprehensive lymphoid molecular testing. 

Key Learning Objectives:

1. Understand the latest advancements in NGS for molecular testing of lymphoproliferative disorders.
2. Discover the Liverpool Lymphoid Network Panel, an innovative NGS solution for lymphoid genomic profiling.
3. Review compelling analytical data from real-world clinical research samples to demonstrate the impact of NGS.

Register now

For Research Use Only. Not for use in diagnostic procedures.
© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified
View our Privacy Policy .